Protecting the Pipeline

LifeGuide HIV drug development faces challenges by Jeannie Wraight and Mariel Selbovitz, MPH Triple and now quad drugs like Gilead’s Atripla and their new compound known...

Right Around the Corner

New meds offer hope for interferon-free regimen by Larry Buhl LifeGuide In the past year several protease inhibitors were introduced for chronic hepatitis C, marking a...

Red Flags

LifeGuide African Americans face medical barriers to HCV treatment by Larry Buhl In the U.S. blacks are disproportionately infected with the hepatitis C virus (HCV), and...

Step Up

LifeGuide HCV testing targets baseball lovers by Larry Buhl This summer a pilot program was launched to raise awareness of the importance of testing for the hepatitis...

Treatment as Prevention

LifeGuide A community perspective on PrEP delves into its pros & cons by Jeannie Gibbs Post-exposure prophylaxis (PrEP) is the provision of antiretrovirals (ARVs) to HIV-negative...

Status Update

LifeGuide Based in San Diego, a prevention model aims to reach everyone Everybody should be tested for HIV. That message is the basis for Lead...

Cutting Glass

A study links anal sex & meth to increased HCV rates among MSMs by Larry Buhl LifeGuide For decades it has been the conventional wisdom that...

When in Rome

The 6th IAS Pathogenesis Conference doesn't really end after the closing session by David Miller In 1987 I attended my first AIDS conference, beginning twenty-four years...

Screen Time

A new study indicates age-based screening can lower hepatitis c mortality by Larry Buhl LifeGuide It is well understood that early detection can prevent serious complications...

Sweet Heart

A statin challenges the drug interaction status quo by Chael Needle LifeGuide Maintaining appropriate levels of lipids (fats or fat-like substances in the blood)—“good” cholesterol (HDL-C),...

LATEST POSTS

Nancy Ledins: Advocate

Unwanted hair is a drag, especially when it propagates on the upper lip of a classy woman like myself. A moustache I don’t need!...